Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido W Jenster

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|June 30, 2022
Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate CancerJan Matthijs Moll, Wilma J Teubel, Sigrun E Erkens, et al.
Cells|July 6, 2023
Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived OrganoidsAnnelies Van Hemelryk, Sigrun Erkens-Schulze, Lifani Lim, et al.
The Prostate|January 17, 2022
Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signallingJ Matthijs Moll, Johannes Hofland, Wilma J Teubel, et al.
European Urology|October 14, 2016
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer PatientsMarzia Del Re, Elisa Biasco, Stefania Crucitta, et al.
Journal of Extracellular Vesicles|August 26, 2021
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancerElena S Martens-Uzunova, Gina D Kusuma, Stefania Crucitta, et al.
Nature Reviews. Urology|July 24, 2020
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needsMichelle M Kouspou, Jenna E Fong, Nadine Brew, et al.
Cancer Research|October 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA MethylationÓscar Monteagudo-García, Paz Nombela, Ángel Carlos Román, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
Cells|November 26, 2022
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor SignalingAnnelies Van Hemelryk, Ingrid Tomljanovic, Corrina M A de Ridder, et al.
European Urology|July 20, 2015
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor CellsWendy Onstenk, Anieta M Sieuwerts, Jaco Kraan, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|June 30, 2022
Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate CancerJan Matthijs Moll, Wilma J Teubel, Sigrun E Erkens, et al.
Cells|July 6, 2023
Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived OrganoidsAnnelies Van Hemelryk, Sigrun Erkens-Schulze, Lifani Lim, et al.
The Prostate|January 17, 2022
Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signallingJ Matthijs Moll, Johannes Hofland, Wilma J Teubel, et al.
European Urology|October 14, 2016
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer PatientsMarzia Del Re, Elisa Biasco, Stefania Crucitta, et al.
Journal of Extracellular Vesicles|August 26, 2021
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancerElena S Martens-Uzunova, Gina D Kusuma, Stefania Crucitta, et al.
Nature Reviews. Urology|July 24, 2020
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needsMichelle M Kouspou, Jenna E Fong, Nadine Brew, et al.
Cancer Research|October 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA MethylationÓscar Monteagudo-García, Paz Nombela, Ángel Carlos Román, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
Cells|November 26, 2022
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor SignalingAnnelies Van Hemelryk, Ingrid Tomljanovic, Corrina M A de Ridder, et al.
European Urology|July 20, 2015
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor CellsWendy Onstenk, Anieta M Sieuwerts, Jaco Kraan, et al.
Pageof 3